Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-028690
Filing Date
2022-05-12
Accepted
2022-05-12 20:22:39
Documents
1
Period of Report
2022-05-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5760
  Complete submission text file 0001209191-22-028690.txt   7404
Mailing Address 339 NORTH GRANADOS AVE SOLANA BEACH CA 92075
Business Address
COUGHLIN TIMOTHY (Reporting) CIK: 0001376043 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36257 | Film No.: 22919760

Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Issuer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations